isothiocyanic acid has been researched along with Retinal Neovascularization in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chikaraishi, Y; Hara, H; Shimazawa, M; Yokota, K; Yoshino, K | 1 |
1 other study(ies) available for isothiocyanic acid and Retinal Neovascularization
Article | Year |
---|---|
CB-12181, a new azasugar-based matrix metalloproteinase/tumor necrosis factor-alpha converting enzyme inhibitor, inhibits vascular endothelial growth factor-induced angiogenesis in vitro and retinal neovascularization in vivo.
Topics: ADAM Proteins; ADAM17 Protein; Angiogenesis Inhibitors; Animals; Animals, Newborn; Cell Proliferation; Cells, Cultured; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Endothelial Cells; Enzyme Inhibitors; Humans; Hydroxamic Acids; Ischemia; Isothiocyanates; Mice; Mice, Inbred C57BL; Retinal Neovascularization; Sulfones; Tumor Necrosis Factor-alpha; Vascular Endothelial Growth Factor A | 2009 |